Eisai Corp. has announced that the FDA has approved its Lusedra (fospropofol disodium) Injection, an intravenous sedative-hypnotic agent for monitored anesthesia care sedation. The injection is for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback